Yan Gu1, Xiaoliang Qi, Shanyu Guo. 1. Department of General Surgery, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200011, China. yangu@sjtu.edu.cn
Abstract
PURPOSE: To evaluate lymphangiogenesis in patients with breast carcinoma, explore the underlying mechanism, and study the relationship between lymphangiogenesis and progression of breast carcinoma. METHODS: Sixty-one cases of breast carcinoma with complete clinical and pathological data were analyzed. Using an anti-podoplanin monoclonal antibody, an immunohistochemical study was made of all specimens to detect lymphatic vessel density (LVD) and to investigate its clinicopathological and prognostic value. VEGF-C and VEGF-D were observed by RT-PCR and immunostaining to investigate their clinicopathological and prognostic values and their relationship with lymphangiogenesis. RESULTS: LVD in breast carcinoma (6.28+/-3.73) was significantly higher than in benign mammary lesions (0.50+/-1.27), P<0.01 and was significantly associated with lymphatic metastasis and high TNM stage, P<0.01. The level of VEGF-C and VEGF-D expression was also significantly higher in breast carcinomas than in benign mammary lesions, P<0.01. LVD increased significantly with higher expression of VEGF-C and VEGF-D, P<0.01. Patients with high expression of VEGF-C and VEGF-D were observed to be more likely to have a bad outcome, P<0.05. CONCLUSIONS: Lymphangiogenesis was significantly associated with lymph node metastasis, high TNM, and poor outcome in breast carcinoma. LVD may serve as a predictor of lymph node metastasis and a prognostic factor in breast carcinoma. VEGF-C and VEGF-D play an important role in lymphangiogenesis making the carcinoma more aggressive and leading to a poor prognosis.
PURPOSE: To evaluate lymphangiogenesis in patients with breast carcinoma, explore the underlying mechanism, and study the relationship between lymphangiogenesis and progression of breast carcinoma. METHODS: Sixty-one cases of breast carcinoma with complete clinical and pathological data were analyzed. Using an anti-podoplanin monoclonal antibody, an immunohistochemical study was made of all specimens to detect lymphatic vessel density (LVD) and to investigate its clinicopathological and prognostic value. VEGF-C and VEGF-D were observed by RT-PCR and immunostaining to investigate their clinicopathological and prognostic values and their relationship with lymphangiogenesis. RESULTS: LVD in breast carcinoma (6.28+/-3.73) was significantly higher than in benign mammary lesions (0.50+/-1.27), P<0.01 and was significantly associated with lymphatic metastasis and high TNM stage, P<0.01. The level of VEGF-C and VEGF-D expression was also significantly higher in breast carcinomas than in benign mammary lesions, P<0.01. LVD increased significantly with higher expression of VEGF-C and VEGF-D, P<0.01. Patients with high expression of VEGF-C and VEGF-D were observed to be more likely to have a bad outcome, P<0.05. CONCLUSIONS: Lymphangiogenesis was significantly associated with lymph node metastasis, high TNM, and poor outcome in breast carcinoma. LVD may serve as a predictor of lymph node metastasis and a prognostic factor in breast carcinoma. VEGF-C and VEGF-D play an important role in lymphangiogenesis making the carcinoma more aggressive and leading to a poor prognosis.
Authors: Roland Sedivy; Johann Beck-Mannagetta; C Haverkampf; Walter Battistutti; Selma Hönigschnabl Journal: J Oral Pathol Med Date: 2003-09 Impact factor: 4.253
Authors: S J Mandriota; L Jussila; M Jeltsch; A Compagni; D Baetens; R Prevo; S Banerji; J Huarte; R Montesano; D G Jackson; L Orci; K Alitalo; G Christofori; M S Pepper Journal: EMBO J Date: 2001-02-15 Impact factor: 11.598
Authors: Echoe M Bouta; Connor W McCarthy; Alexander Keim; Han Bing Wang; Ryan J Gilbert; Jeremy Goldman Journal: Acta Biomater Date: 2010-10-23 Impact factor: 8.947
Authors: Steven A Stacker; Steven P Williams; Tara Karnezis; Ramin Shayan; Stephen B Fox; Marc G Achen Journal: Nat Rev Cancer Date: 2014-03 Impact factor: 60.716
Authors: F Morgillo; F De Vita; G Antoniol; M Orditura; P P Auriemma; M R Diadema; E Lieto; B Savastano; L Festino; M M Laterza; A Fabozzi; J Ventriglia; A Petrillo; F Ciardiello; A Barbarisi; F Iovino Journal: Curr Oncol Date: 2013-08 Impact factor: 3.677
Authors: Chu-An Wang; Paul Jedlicka; Aaron N Patrick; Douglas S Micalizzi; Kimberly C Lemmer; Erin Deitsch; Matias Casás-Selves; J Chuck Harrell; Heide L Ford Journal: J Clin Invest Date: 2012-04-02 Impact factor: 14.808
Authors: Joanna A Niemiec; Agnieszka Adamczyk; Aleksandra Ambicka; Anna Mucha-Małecka; Wojciech M Wysocki; Beata Biesaga; Marek Ziobro; Ida Cedrych; Aleksandra Grela-Wojewoda; Małgorzata Domagała-Haduch; Joanna Wysocka; Janusz Ryś; Beata Sas-Korczyńska Journal: Am J Transl Res Date: 2017-03-15 Impact factor: 4.060